Clinical Trials

Search for trials
Clinical Trial
  • Status: Not yet recruiting
  • Phase: N/A
  • Intervention Type: Dietary Supplement
  • Participants: 70
  • Start Date: September 2021
Interest of Nutritional Care of Children With Sickle Cell Disease on Bone Mineral Density and Body Composition
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 2
  • Intervention Type: Other, Behavioral
  • Participants: 366
  • Start Date: September 1, 2021
Hybrid Effectiveness-Implementation Trial of Guided Relaxation and Acupuncture for Chronic Sickle Cell Disease Pain
Search for trials
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 1
  • Intervention Type: Drug
  • Participants: 40
  • Start Date: August 2021
Kinetics of Donor Red Blood Cell Survival in Sickle Cell Disease
Clinical Trial
  • Status: Not yet recruiting
  • Phase: N/A
  • Intervention Type: Other
  • Participants: 10
  • Start Date: August 1, 2021
Fitness Intervention Trial in Adults With Sickle Cell Disease (SCD Fit): A Feasibility Study
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 2/Phase 3
  • Intervention Type: Drug, Other
  • Participants: 200
  • Start Date: August 1, 2021
Study of Montelukast In ChiLdrEn With Sickle Cell Disease (SMILES)
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 1/Phase 2
  • Intervention Type: Genetic
  • Participants: 15
  • Start Date: August 2021
A Phase I/II Study of the Correction of a Single Nucleotide Mutation (Adenosine --> Thymine [A-->T]) in Autologous CD34+ Hematopoietic Stem Cells to Convert HbS to HbA for Treating Severe Sickle Cell Disease
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 1
  • Intervention Type: Drug
  • Participants: 30
  • Start Date: July 26, 2021
A Phase IB Randomized, Placebo-Controlled Study Evaluating the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of Crovalimab for the Management of Acute Uncomplicated Vaso-Occlusive Episodes (VOE) in Patients With Sickle Cell Disease (SCD)
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 4
  • Intervention Type: Drug
  • Participants: 140
  • Start Date: July 9, 2021
An Indian Multi-centric Phase IV Study to Assess the Safety of Crizanlizumab With or Without Hydroxyurea Therapy in Sickle Cell Disease Patients With Vaso-occlusive Crises.
Clinical Trial
  • Status: Not yet recruiting
  • Phase: N/A
  • Intervention Type: Behavioral, Device
  • Participants: 60
  • Start Date: July 2021
Home-Based Intervention for Chronic Pain in Adults With Sickle Cell Disease (HIPAS)
Clinical Trial
  • Status: Recruiting
  • Participants: 50
  • Start Date: July 2021
Discarded Bone Marrow for Hematology Research
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 2
  • Intervention Type: Dietary Supplement, Drug
  • Participants: 100
  • Start Date: July 2021
Management of Severe Acute Malnutrition in Children With Sickle Cell Disease Greater Than 5 Years of Age Living in Northern Nigeria
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 3
  • Intervention Type: Drug
  • Participants: 280
  • Start Date: July 1, 2021
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of a Single Dose of Inclacumab to Reduce Re-admission in Participants With Sickle Cell Disease and Recurrent Vaso-occlusive Crises
Showing 1-12 of 302